Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

P1813Impact of cardiac MRI imaging on detection rates of myocarditis

View through CrossRef
Abstract Background The Lake Louise Criteria for the diagnosis of myocarditis by cardiac MRI (CMR) was published in 2009 (JACC April 2009; 53(17): 1475–1487) utilizing T2 STIR, “early” gadolinium enhancement (EGE) and late gadolinium enhancement (LGE). In 2012, our CMR unit adopted a chest pain protocol to enhance detection of inflammatory heart disease, using all 3 pulse sequences. In 2017, T1 relaxing mapping and T2 relaxation mapping were added to the chest pain protocol. Purpose This study was designed to assess the impact of pulse sequence changes in the CMR chest pain protocol on the detection rate of myocarditis. Methods An institutional cardiac imaging database was queried for all patients with chest pain who underwent a CMR study from 2009 thru 2018. The number of newly diagnosed cases of myocarditis per year was computed, based on the prevailing CMR diagnostic criteria at that time. The detection rate of new myocarditis cases per year, was calculated by dividing the number of new cases by the total of CMR studies performed for evaluation of chest pain, during each calendar year. Results Of the 4,946 patients in the cardiac imaging database, 2,126 patients underwent CMR imaging for complaints of chest pain. Detection rates of myocarditis by year are shown in Figure 1. Prior to inclusion of T1 STIR pulse sequences, CMR detection of myocarditis was nearly nil. Use of T2 STIR imaging allowed for an increased rate of myocarditis detection. However, addition of T1 mapping and T2 mapping in 2017 resulted in another increase in myocarditis detection rates from baseline. Figure 1. Detection rate of myocarditis. Conclusions Detection rates of myocarditis using CMR were improved by using T2 STIR pulse sequences, per the initial Lake Louise Criteria. Further enhancement of myocarditis detection rates is achieved by addition of T1 and T2 mapping. These CMR impact data provide additional support for the adoption of the recently modified Lake Louise Criteria (JACC Dec 2018; 72(24): 3158–3176).
Title: P1813Impact of cardiac MRI imaging on detection rates of myocarditis
Description:
Abstract Background The Lake Louise Criteria for the diagnosis of myocarditis by cardiac MRI (CMR) was published in 2009 (JACC April 2009; 53(17): 1475–1487) utilizing T2 STIR, “early” gadolinium enhancement (EGE) and late gadolinium enhancement (LGE).
In 2012, our CMR unit adopted a chest pain protocol to enhance detection of inflammatory heart disease, using all 3 pulse sequences.
In 2017, T1 relaxing mapping and T2 relaxation mapping were added to the chest pain protocol.
Purpose This study was designed to assess the impact of pulse sequence changes in the CMR chest pain protocol on the detection rate of myocarditis.
Methods An institutional cardiac imaging database was queried for all patients with chest pain who underwent a CMR study from 2009 thru 2018.
The number of newly diagnosed cases of myocarditis per year was computed, based on the prevailing CMR diagnostic criteria at that time.
The detection rate of new myocarditis cases per year, was calculated by dividing the number of new cases by the total of CMR studies performed for evaluation of chest pain, during each calendar year.
Results Of the 4,946 patients in the cardiac imaging database, 2,126 patients underwent CMR imaging for complaints of chest pain.
Detection rates of myocarditis by year are shown in Figure 1.
Prior to inclusion of T1 STIR pulse sequences, CMR detection of myocarditis was nearly nil.
Use of T2 STIR imaging allowed for an increased rate of myocarditis detection.
However, addition of T1 mapping and T2 mapping in 2017 resulted in another increase in myocarditis detection rates from baseline.
Figure 1.
Detection rate of myocarditis.
Conclusions Detection rates of myocarditis using CMR were improved by using T2 STIR pulse sequences, per the initial Lake Louise Criteria.
Further enhancement of myocarditis detection rates is achieved by addition of T1 and T2 mapping.
These CMR impact data provide additional support for the adoption of the recently modified Lake Louise Criteria (JACC Dec 2018; 72(24): 3158–3176).

Related Results

Hydatid Disease of The Brain Parenchyma: A Systematic Review
Hydatid Disease of The Brain Parenchyma: A Systematic Review
Abstarct Introduction Isolated brain hydatid disease (BHD) is an extremely rare form of echinococcosis. A prompt and timely diagnosis is a crucial step in disease management. This ...
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
Myocarditis and Pericarditis following COVID-19 Vaccination in Thailand
Background: Myocarditis and pericarditis cases following Coronavirus 2019 (COVID-19) vaccination were reported worldwide. In Thailand, COVID-19 vaccines were approved for emergency...
Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines
Myocarditis and pericarditis in individuals exposed to the Ad26.COV2.S, BNT162b2 mRNA, or mRNA-1273 SARS-CoV-2 vaccines
ImportanceThere is a high level of public and professional interest related to potential safety issues of the COVID-19 vaccines; however, no serious adverse cardiovascular events w...
RELATIONSHIP BETWEEN MYOCARDITIS AND DENGUE
RELATIONSHIP BETWEEN MYOCARDITIS AND DENGUE
Introduction: Myocarditis, an inflammation of the heart muscle, can arise as a complication of dengue fever, a mosquito-borne disease. It is essential to adopt a multidisciplinary ...
Autopsy Proven Fatal COVID-19 Vaccine-Induced Myocarditis
Autopsy Proven Fatal COVID-19 Vaccine-Induced Myocarditis
Background: COVID-19 vaccines have been linked to myocarditis which in some circumstances can be fatal. This systematic review aims to investigate potential causal links between CO...
Adverse cardiac events following mRNA COVID-19 vaccination: A systematic review and meta-analysis
Adverse cardiac events following mRNA COVID-19 vaccination: A systematic review and meta-analysis
Context: Although have been proven able to control the prevalence of coronavirus disease-19 (COVID-19), Pfizer-BioNTech and Moderna COVID-19 vaccines are reported to have possible ...
Analysis on the MRI and BAEP  Results of Neonatal Brain with Different Levels of Bilirubin
Analysis on the MRI and BAEP  Results of Neonatal Brain with Different Levels of Bilirubin
Abstract Background:To explore whether there is abnormality of neonatal brains’ MRI and BAEP with different bilirubin levels, and to provide an objective basis for early di...
Analysis on the MRI and BAEP  Results of Neonatal Brain with Different Levels of Bilirubin
Analysis on the MRI and BAEP  Results of Neonatal Brain with Different Levels of Bilirubin
Abstract Background:To explore whether there is abnormality of neonatal brains’ MRI and BAEP with different bilirubin levels, and to provide an objective basis for early di...

Back to Top